Families using GLP-1s are spending less on food, from grocery stores to restaurants, according to a study published Dec. 18 ...

Weight loss isn't the only change Individuals who are taking a GLP-1 weight loss medicine are seeing. They also tend to spend ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the approval of a GLP-1 pill for weight ...

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...

Sprout Health Serves as Case Study for Provider Model Structure, Program Costs, and FDA-vs-Compounded Disclosure Standards ...

The approval gives Novo Nordisk a head start over chief rival Eli Lilly, which is racing to launch its own obesity pill.

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...

Enjoying a holiday feast doesn't have to be challenging for people on GLP-1 medications, but experts caution that certain ...

Morrisons has partnered with Liverpool, U.K.-based sports nutrition, health and wellness brand Applied Nutrition on an ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...